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Solubilized membrane proteins of Hep G2 cells were electrophoretically separated on polyacrylamide gels and electro- 
transferred onto nitrocellulose paper. Overlaying the nitrocellulose with human high density lipoproteins conjugated to 
colloidal gold revealed the presence of a single protein band with an apparent molecular mass of 80 kDa. Binding of 
the conjugates to this protein was specific for high density lipoproteins in as much as it was effectively displaced by an 
excess of unlabelled high density lipoproteins but not by a similar excess of unlabelled low density lipoproteins. Binding 
was not dependent on Ca*+ as 10 mM EDTA had no effect. The binding activity of the solubilized membranes was in- 
creased by incubating the cells with non-lipoprotein cholesterol. This was detected on electroblots and quantified with 
a new dot blot assay using the colloidal gold-high density lipoprotein conjugates. 
HDL receptor; Colloidal gold; Electroblotting; Dot blotting; Ligand blotting; (Hep G2 cell) 
1. INTRODUCTION 
High density lipoproteins are crucial to the 
orderly metabolism of cellular cholesterol. This in- 
volves transport of cholesterol between organs 
which in turn requires regulated interaction be- 
tween cells and HDL. The demonstration of high- 
affinity binding sites for HDL apoproteins A-I, A- 
II and A-IV [l-3] which appear to mediate either 
the delivery of cholesterol to cells [4], or the 
transfer of cholesterol out of cells [5,6], favours 
the presence of specific receptors. This has been 
strengthened by the demonstration of proteins 
from membranes of several organs that bind 
Correspondence address: A.M. Kambouris, CSIRO, Division 
of Human Nutrition, Kintore Ave., Adelaide, SA 5000, 
Australia 
Abbreviations: HDL, high density lipoproteins; LDL, low den- 
sity lipoproteins; VLDL, very low density lipoproteins; MEM, 
minimal essential medium; PBS, phosphate buffered saline; 
PMSF, phenylmethylsulfonyl fluoride; BSA, bovine serum 
albumin 
specifically either to HDLs (which contains no 
apoprotein E), or to the HDL apoproteins. 
However, several apparently distinct proteins have 
been reported. The first, from sheep adrenal, rat 
liver and rat kidney is an 80 kDa protein [7,8] 
whereas that from human placenta is larger 
(120 kDa) [9]. Graham and Oram [lo] have iden- 
tified a 110 kDa protein in membranes of several 
species of cells which binds HDL and is regulated 
by intracellular cholesterol evels. 
We describe in this report a new technique for 
detecting and quantifying the activity of the HDL3 
binding protein. It is based on the recently publish- 
ed and highly sensitive method of Roach et al. [l 11 
for the detection of the LDL receptor using col- 
loidal gold-complexed lipoproteins and the 
amplification of the colour by silver staining. 
Adapting this technique for HDL, we have 
demonstrated a HDL-binding protein from the 
human hepatoma cell line, Hep G2, using colloidal 
gold-HDL3 conjugates. Furthermore, we have 
shown by electroblotting and quantitative dot blot- 
ting that this protein is up-regulated by incubating 
the cells in the presence of cholesterol. 
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2. MATERIALS AND METHODS 
Lipoproteins (HDLs, d = 1.125-1.21 g/ml and LDL, d = 
1.025-1.05 g/ml) were obtained from normolipemic human 
plasma by preparative ultracentrifugation [12] (including a 
wash to remove albumin), dialyzed against 0.15 M NaCl, pH 
7.4, sterilized using a 0.45 pm Millipore filter and used within 
2 weeks of preparation. 
Colloidal gold was prepared by the method of Frens [13]: 
2.8 ml of 1% (w/v) trisodium citrate were added to 100 ml of 
a 0.01% (w/v) HAuCh boiling solution and the boiling was 
continued under reflux until the colour became red and did not 
change. 
HDLs was conjugated to colloidal gold essentially as de- 
scribed for LDL [14]; 5 ml of colloidal gold was jetted into a 
tube containing 80 pg of HDLs protein diluted to a volume of 
0.5 ml with deionized water. Conjugates were pelleted by cen- 
trifugation at room temperature at 10000 X g for 20 min in 
Bunzel polypropylene centrifuge tubes and washed once in 
deionized water under the same conditions. Conjugates were 
prepared fresh when required. 
The human hepatoma cell line, Hep G2, was grown in 
minimal essential medium (MEM) supplemented with 10 ml/l 
of 100 x MEM vitamins, 0.11 g/l of sodium pyruvate, 1.17 g/l 
of L-glutamine and 10% (v/v) fetal calf serum. To increase the 
cellular concentration of free cholesterol, confluent monolayers 
were washed with PBS containing 1 mg/ml fatty acid free 
albumin and further incubated with culture medium containing 
non-lipoprotein cholesterol (5-50 &ml) and progesterone 
(20 ,ug/ml) as described by Oram [15]. 
Preparation and solubilization of cellular membranes was 
essentially as described elsewhere for rat livers [16]. The Hep G2 
cells were scraped from the culture flasks, supplemented in 
20 mM Tris-HCl buffer, pH 7.5, containing 0.15 M NaCl, 
1 mM CaClz and 1 mM PMSF and homogenized for 2 periods 
of 15 s with a Janke and Kinkel Ultra Tarrax (Staufen, FRG) 
set at 10. The 3000-100000 x g fraction was prepared by 
ultracentrifugation and the pellet was suspended in 0.25 mM 
Tris-maleate, pH 6.5, containing 1 mM PMSF and sonicated 
for 2 periods of 20 s using a Branson sonifier (Danbus, USA) 
set at 4. Triton X-100 was then added to a final concentration 
of 1% (w/v). Insoluble material was removed by centrifugation 
at 100000 x g for 1 h at 4°C and the detergent was removed us- 
ing Amberlite XAD-2 [16]. Finally, the insoluble debris was 
removed by centrifugation at 10000 x g for 10 min and the 
solution kept at 4°C for up to 2 weeks or frozen at -80°C. 
Unreduced, unheated solubilized membrane proteins 
(100 /g/well) were separated by electrophoresis on 
polyacrylamide gels containing SDS [17] and electrotransferred 
onto nitrocellulose paper according to Bumette [18] using a 
water cooled Bio-Rad apparatus for 18 h at 180 mA. Gels were 
calibrated with either Bio-Rad or Pharmacia low molecular 
mass protein standards. 
For dot blot assays, the solubilized Hep G2 cell membrane 
proteins were spotted onto nitrocellulose paper using a Bio-Rad 
dot blot apparatus. Samples (2/g) were applied in 20~1 of 
125 mM Tris-maleate, pH 6.5, containing 1 mM PMSF and 
allowed to filter through the rdtrocellulose paper by gravity at 
room temperature. 
Detection of HDLp binding activity on electroblots and dot 
blots was done essentially as described for LDL [ll]. The 
nitrocellulose strips were first incubated in quenching buffer 
(60 mM Tris-HCl, pH 8.0, containing 25 mM NaCl and 
40 mg/ml BSA) for 1 h at room temperature and subsequently 
for 1 h in incubation buffer (60 mM Tris-HCl, pH 8.0, contain- 
ing 25 mM NaCl, 10 mM EDTA and 20 mg/ml BSA) contain- 
ing 20 fig/ml colloidal gold-HDLs conjugates. For competition 
studies, a 25-fold excess of unlabelled HDLs or LDL was in- 
cluded in the incubation buffer along with the conjugated 
HDLs. After the gold-ligand overlay, the nitrocellulose strips 
A B C 
Fig. 1. Competitive displacement of colloidal gold-HDL, 
conjugate binding to a protein band on nitrocellulose. 
Solubilized membrane proteins from Hep G2 cells, 100 cg, were 
subjected to electrophoresis and electroblotted onto 
nitrocelhtlose paper. The electroblots were incubated with 
2Opg/ml of colloidal gold-HDLs conjugates only (A), in the 
presence of a 25-fold excess of unlabelled HDLs (B) or a similar 
excess of unlabelled LDL (C). The nitrocellulose strips were 
subsequently incubated in silver stain. 
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were rinsed extensively with deionized water then with 20 mM 
citrate buffer, pH 3.85, before being silver stained [19] as 
described [ 111. For quantitation, the dot blots were soaked in 
toluene to render them transparent and scanned using an LKB 
2202 ultrascan laser densitometer interfaced to a Hewlett 
Packard computing integrator. 
3. RESULTS 
Among the solubilized membrane proteins of 
Hep G2 cells, only one protein interacted with the 
gold-HDLs after electrophoresis through a 
polyacrylamide gel and electrotransfer onto 
nitrocellulose. Lane A of fig.1 shows the single 
band which was visualized after overlaying with 
the HDL3 conjugates. This band corresponded to 
a protein with an apparent molecular mass of 
about 80 kDa. The interaction of the conjugates 
with this protein is specific for HDL3 in that the 
gold-HDL3 was displaced by a 25fold excess of 
unlabelled HDL3 (fig. 1, lane B) but not by a 
similar excess of unlabelled LDL (fig. 1, lane C). 
The regulation of the expression of this protein 
in response to the cholesterol content of the 
medium is shown in fig.2. The binding of gold- 
HDL3 to the 80 kDa membrane protein increased 
when Hep G2 cells were incubated for 24 h in 
medium containing between 5 and 50pg/ml of 
non-lipoprotein cholesterol. The increase in 
cellular cholesterol was entirely in the unesterified 
fraction. The HDL binding protein appeared to be 
up-regulated by incubating the cells in the presence 
of cholesterol because the coloration of the band 
0 5 10 20 50 
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Fig.2. The effect of cholesterol on the HDL binding protein. 
Solubilized membrane proteins, 100 fig, from Hep G2 cells 
incubated in the presence of the indicated amount of cholesterol 
were subjected to electrophoresis and electroblotted onto 
nitrocellulose paper. The electroblots were incubated with 
20 /rg/ml of colloidal gold-HDLp conjugates and subsequently 
incubated in silver stain. 
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Fig.3. The effect of cholesterol on the specific HDL binding 
activity of Hep G2 cells measured by the dot blot assay. 
Solubilized membrane proteins (2,ug) from cells incubated in 
the presence of the indicated amount of cholesterol were dot 
blotted onto nitrocellulose and incubated with 20pg/ml of 
colloidal gold-HDLp conjugates in the absence (total binding) 
and presence (nonspecific binding) of 1 mg/ml unlabelled 
HDLs. The nitrocellulose was then silver stained and scanned 
with a laser densitometer interfaced to a computing integrator. 
The specific binding was obtained by subtracting the 
nonspecific binding from the total binding and expressed as 
integrator peak height in mm. 
was more intense for cells incubated in the 
cholesterol-containing medium than for cells in- 
cubated in the absence of cholesterol (fig.2). This 
finding was confirmed with the dot blot assay. The 
HDL3 binding activity increased in a saturable 
manner with the amount of cholesterol in the 
medium (fig.3). Up to a two-fold increase in 
specific HDL3 binding was observed. 
4. DISCUSSION 
This study demonstrates that the protein from 
Hep G2 cells which binds HDL3 specifically is sen- 
sitively regulated by cellular free cholesterol. The 
binding of the gold-labelled HDL3 was effectively 
displaced by excess unlabelled HDL3 but not by 
unlabelled LDL and the protein differed from the 
LDL receptor in having a low molecular mass: 
80 kDa vs 130 kDa for the LDL receptor under 
similar electrophoretic onditions [20]. Also unlike 
the binding to the LDL receptor, the binding of 
HDL3 to this protein is independent of Ca*+; the 
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coloration was observed in the presence of 10 mM 
EDTA. 
Hep G2 cells have been shown by Dashti et al. 
[21] to bind and degrade human lz51-HDL. They 
however found the interaction to be rather non- 
specific in that human unlabelled VLDL and LDL 
were as effective in displacing 1251-HDL as 
unlabelled HDL. In contrast, Hoeg et al. [22] 
found that radioiodinated apo E-free HDL in- 
teracted in a specific manner with Hep G2 cells as 
well as with membranes from human liver biop- 
sies; unlabelled LDL was not able to displace the 
binding of 12’1-HDL. 
The molecular masses of the cellular proteins 
that bind HDL have been reported to vary between 
80 and 120 kDa and in this study appeared to be 
approx. 80 kDa. It remains to be seen whether 
there are indeed multiple distinct proteins that 
specifically bind HDL or whether the smaller pro- 
teins represent biologically active degradation 
fragments. 
The findings with the cholesterol-incubated Hep 
G2 cells are a direct demonstration of the 
physiological role of the putative HDL receptor 
and the sensitivity of our technique to detect a dif- 
ference in its expression. The increase in the 
80 kDa protein is entirely consistent with the 
greater binding of 1251-HDL~ to these cells ob- 
served by Hoeg et al. [22] following incubation 
with cholesterol. Similar results have also been 
reported for the binding of i2’I-HDL to cholesterol 
loaded fibroblasts and arterial smooth muscle cells 
[23]. Clearly, the expression of the HDL binding 
protein is stimulated in cells when there is a need 
to transfer excess cholesterol out of the cell. 
However, HDL binding activity also increases 
when rat adrenocortical cells are stimulated to 
raise corticosteroid production, a process requiring 
cholesterol [24]. 
The up-regulation of the putative HDL receptor 
is in contrast to the down-regulation of the LDL 
receptor others [25] and ourselves (not shown) 
have observed in Hep G2 cells incubated with 
cholesterol. These reciprocal changes may however 
be regulated via a common mechanism and the 
concentration of unesterified cholesterol is most 
likely to play a role. We have also recently ob- 
served a similar reciprocal relationship between the 
LDL and HDL receptor activities in the livers of 
rats fed fish oil [26]. The concentration of 
unesterified cholesterol in the livers of these rats 
may well rise because the production and secretion 
of VLDL [27] and therefore the secretion of 
cholesterol is severely inhibited by the dietary oils. 
The livers of the fish oil fed-rats, like the Hep G2 
cells incubated with cholesterol, probably attempt 
to decrease the concentration of unesterified 
cholesterol by down-regulating their LDL recep- 
tors to reduce the uptake of cholesterol-rich LDL 
[28]. It is also tempting to suggest that up- 
regulating the putative HDL receptor may lead to 
an enhanced efflux of cholesterol from these livers 
and Hep G2 cells in keeping with the involvement 
of HDL in the efflux of cholesterol from 
peripheral cells in culture [5,6]. 
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